Showing papers in "Pacing and Clinical Electrophysiology in 1996"

Multisite pacing for end-stage heart failure: early experience.

Abstract: Our objective was to improve hemodynamics by synchronous right and left site ventricular pacing in patients with severe congestive heart failure (CHF). Previous studies reported a benefit of dual chamber pacing with a short AV delay in patients with severe CHF. Other works, however, show contradictory results. Deleterious effects due to a desynchronization of right (RV) and left ventricular (LV) contractions have been suggested. This study included eight subjects with widened QRS and end-stage heart failure despite maximal medical therapy, who refused, or were not eligible to undergo heart transplantation, Each patient underwent a baseline, invasive hemodynamic evaluation with insertion of three temporary leads to allow different pacing configurations, including RV apex and outflow tract pacing, and biventricular pacing between the RV outflow tract and LV and RV apex and LV. According to the results of this baseline study, the configuration of preexistent pacemakers was modified or new systems were implanted to allow biventricular pacing, which, in patients with sinus rhythm, was atrial triggered. Biventricular pacing increased the mean cardiac index (CI) by 25% (from a baseline of 1.83 +/- 0.30 L/min per m2, P < 0.006), decreased the mean V wave by 26% (from a baseline of 36 +/- 12 mmHg, P < 0.004), and decreased pulmonary capillary wedge pressure by 17% (from a baseline of 31 +/- 10 mmHg, P < 0.01). Four patients died (1 preoperatively, 1 intraoperatively, 2 within 3 months, and 1 of a noncardiac cause). The four surviving patients have clinically improved from New York Heart Association Functional Class IV to Class II. In these survivors, CI decreased by 15% (P < 0.007) when multisite pacing was turned off during follow-up. In patients with end-stage heart failure, multisite pacing may be associated with a rapid and sustained hemodynamic improvement.

Tachycardiomyopathy: Mechanisms and Clinical Implications

Abstract: It is well recognized that some forms of myocardial dysfunction believed to be structural and irreversible, might be reversible, as illustrated in ischemic heart disease by myocardial stunning' and hibernation.^ Another form of reversible myocardial dysfunction is caused by chronic arrhythmias, and is known as tachycardiomyopathy. This tachycardia-induced cardiomyopathy was shown to occur both in experimental models' and in patients with incessant supraventricular'''^ or ventricular^ arrhythmias. Cessation ofthe arrhythmia results in recovery of myocardial function. Tho prevalence of snpraventricular or ventricular arrhythmias among patients with heart failure is high. Given the availability of safe and effective means to treat (and in many cases to cnre) cardiac arrhythmias,^"'" it is of paramount importance to properly recognize those patients with heart failnre in whom a tachycardiomyopathy may be present. Since the diagnosis of tachycardiomyopathy may sometimes he strikingly troublesome, and frequently made only in retrospect, the question on whether some patients are not being treated as heart failure patients, when in reality they are tachycardiomyopathy patients, is sound and should be addressed. Otherwise, the opportimity to significantly improve these patients cardiac function will be missed. In this review we shall discuss the available information regarding the occurrence of tachycardiomyopathy, and the pathophysiological and therapeutic implications of this syndrome in clinical practice.

The Effect of Ventricular Activation Sequence on Cardiac Performance During Pacing

Abstract: The aim of this study was to evaluate the importance of a normal ventricular activation pattern for cardiac performance. In nine mongrel clogs, atrial pacing was compared to AV synchronous pacing at three different A V delays (150, 100, and 60 nis). In six dogs, proximal septal AV synchronous pacing was compared to apical A V synchronous pacing at three different A V delays. AV synchronous pacing was performed after RF induced complete heart block. Hemodynarnics were evaluated by assessment of positive and negative dP/dt, cardiac output, and left ventricular and pulmonary pressures. Atrial pacing was superior to AV synchronous pacing with respect to positive and negative dP/dt and cardiac output. This difference was present at all AV delays. Proximal septal pacing was associated with a higher positive and negative dP/dl compared to apical pacing at all AV delays. Left ventricular activation time was significantly shorter during proximal septal pacing than during apical pacing (88 ± 4 vs 115 ± 4 ms, P < 0.001). We conclude that atrial and proximal septal pacing improves cardiac function and shortens the ventricular activation time compared to apical AV synchronous pacing independent of the AV interval.

Electromagnetic Interference of Pacemakers by Mobile Phones

Abstract: The topic of interference of pacemakers by mobile phones has evoked a surprisingly strong interest, not only in pacemaker patients, but also in the public opinion. The latter is the more surprising, as in the past, the problem of interference has scarcely found the attention that it deserves in the interest of the patient. It was the intention of our investigation to test as many pacemaker models as possible to determine whether incompatibility with mobile phones of different modes may exist, using an in vitro measuring setup. We had access to 231 different models of 20 manufacturers. During the measurements, a pulse generator together with a suitable lead was situated in a 0.9 g/L saline solution, and the antenna of a mobile phone was positioned as close as possible. If the pulse generator was disturbed, the antenna was elevated until interference ceased. The gap in which interference occurred was defined as “maximum interference distance.” All three nets existing in Germany, the C-net (450 MHz, analogue), the D-net (900 MHz, digital pulsed), and the E-net. (1,800 MHz, digital pulsed) were tested in succession. Out of 231 pulse generator models, 103 pieces corresponding to 44.6% were influenced either by C- or D-net, if both results were totaled. However, this view is misleading as no patient will use C- and D-net phones simultaneously. Separated into Cor D-net interference, the result is 30.7% for C or 34.2% for D, respectively, of all models tested. The susceptible models represent 18.6% or 27% of today's living patients, respectively. All models were resistant to the E-net. With respect to D-net phones, all pacemakers of six manufacturers proved to be unaffected. Eleven other manufacturers possessed affected and unaffected models as well. A C-net phone only prolonged up to five pacemaker periods within 10 seconds during dialing without substantial impairment to the patient. Bipolar pacemakers are as susceptible as unipolar ones. The following advice for patients and physicians can be derived from our investigations: though 27% of all patients may have problems with D-net phones (not C- or E-net), the application should generally not be questioned. On the contrary, patients with susceptible devices should be advised that a distance of 20 cm is sufficient to guarantee integrity of the pacemaker with respect to hand held phones. Portables, on the other hand, should have a distance of about 0.5 m. Pacemaker patients really suffering from mobile phones are very rare unless the phone is just positioned in the pocket over the pulse generator. The contralateral pocket or the belt position guarantees, in 99% of all patients, undisturbed operation of the pacemaker. A risk analysis reveals that the portion of patients really suffering from mobile phones is about 1 out of 100,000. Nevertheless, it would be desirable in the future if implanting physicians would use only pacemakers with immunity against mobile phones as guaranteed by the manufacturers

Safe Performance of Magnetic Resonance Imaging on Five Patients with Permanent Cardiac Pacemakers

Abstract: UNLABELLED Five patients with permanent cardiac pacemakers (Pacesetter models 261, 285, 2016, 2020, 2022) underwent magnetic resonance imaging (MRI). Only one patient (underlying rhythm asystole) was pacemaker dependent. A variety of pacing configurations (single and dual chamber; unipolar and bipolar; sensor and nonsensor driven) were scanned. A thorough evaluation of each pacing system was performed before and after scanning including determination of pacing and sensing thresholds. During MRI the patient was monitored using either ECG, pulse oximetry, or direct voice contact. In four patients heavy dressings were applied over the pacemaker pocket site. Patients were asked to report any symptoms experienced during MRI. RESULTS The four nonpacemaker dependent patients remained in sinus rhythm throughout the MRI. During and after the MRI all pacemakers continued to function normally except for one transient pause of approximately 2 seconds (noted by pulse oximeter) toward the end of the scan. This occurred in a pacemaker dependent patient with a unipolar dual chamber device programmed DOO. No patient experienced any torque or heat sensation. CONCLUSION When appropriate strategies are used our experience suggests that MRI may be performed, when necessary, with an acceptable risk-benefit ratio to the patient. It is unclear whether the isolated pause that was observed was due to the effect of the MRI, an artifact with the monitoring system, or oversensing by the pacemaker. Appropriate patient selection, close monitoring during the scan, and follow-up after MRI are of paramount importance. Further study is necessary to refine the appropriate strategies that could be used to consistently perform MRI safely in a selected pacemaker population.

Changes in Heart Rate Variability with Age

Abstract: Depressed heart rate variability (HRV) after a myocardial infarction is associated with increased mortality. This is thought to be due to reduced parasympathetic activity and heightened sympathetic activity. Aging is associated with depressed HRV, but little is known of the affect of aging on parasympathetic activity. This study examined 56 healthy subjects (age range 40-102 years; 39 women). None had a history of heart disease or were on medication that would affect cardiac function. All had normal resting ECGs, normal heart size on chest X ray, and normal electrolytes. In all subjects, 24-hour Holter recordings were performed and used to measure HRV. In particular, the study examined the affect of age on HRV triangular index, which gives an estimate of overall HRV, and on RMSSD (square root of the mean squared differences of successive normal-to-normal RR intervals), which gives an estimate of short-term components of HRV and is thought to reflect the overall extent of vagal modulations of heart rates. Both these parameters were compared in patients younger and older than 70 years. Each recording lasted at least 17 hours; the majority of recordings were longer than 20 hours. There was a significant decrease in HRV triangular index with age (r = -0.4, P 70 years compared with those < 70 years (38.0 +/- 9.3 vs 31.0 +/- 11, respectively, P < 0.02). There was no significant difference in RMSSD between the two age groups (26.7 +/- 8.2 ms vs 28.4 +/- 11.3 ms, respectively, P = NS). Thus, the study concludes that aging reduces the global measure of HRV and may reflect reduced responsiveness of autonomic activity to external environmental stimuli with age. However, the time-domain short-term components of HRV are not affected by age and, therefore, the fast and presumably vagal modulations of heart rate appear to be maintained.

Regional Disparities of Endocardial Atrial Activation in Paroxysmal Atrial Fibrillation

Abstract: UNLABELLED Previous experimental data suggest that atrial activity is homogeneously distributed during paroxysmal atrial fibrillation (AFib). Little is known about this in human paroxysmal AFib. METHODS Twenty-five men and two women (mean age 49 +/- 11 years; five with structural heart disease) with paroxysmal AFib for a mean 5 +/- 6.2 years despite the use of a mean of 3.6 +/- 1.7 antiarrhythmic drugs underwent atrial mapping. The right atrium was divided into four regions: posterior (intercaval), lateral, anterior, and septal. A 14-pole catheter was positioned to assess complex electrical activity defined as the duration of continuous electrical activity or electrograms with FF intervals < 100 ms for 60 seconds (expressed as percentage of time). In addition, the left atrium (divided into three regions: posterior, anterior, and septal) was explored in 12 patients with a multipolar catheter. RESULTS The complex electrical activity time between all the regions explored was significantly different. In the right atrium, the septal (74% +/- 32%; P = 0.02) and the posterior (63% +/- 32%; P = 0.04) areas were significantly more disorganized than the lateral (22% +/-23%) and anterior (21% +/- 26%) regions. In the left atrium, complex electrical activity was predominant and widely distributed (posterior: 87% +/- 11%; septal: 65% +/- 27%) except in the appendage area (anterior region: 18% +/- 14%). CONCLUSIONS Quantitative assessment of complex electrical activity in both atria in humans shows heterogeneous temporal and spatial distribution. This may have implications for guiding catheter ablation of AFib.

An Implantable Intracardiac Accelerometer for Monitoring Myocardial Contractility

Abstract: As the myocardium contracts isometrically, it generates vibrations that are transmitted throughout the heart. These vibrations can be measured with an implantable microaccelerometer located inside the tip of an otherwise conventional unipolar pacing lead. These vibrations are, in their audible component, responsible for the first heart sound. The aim of this study was to evaluate, in man, the clinical feasibility and reliability of intracavity sampling of Peak Endocardial Acceleration (PEA) of the first heart sound vibrations using an implantable tip mounted accelerometer. We used a unidirectional accelerometer located inside the stimulating tip of a standard unipolar pacing lead: the sensor has a frequency response of DC to 1 kHz and a sensitivity of 5 mV/G (G - 9.81 m/s−2). The lead was connected to an external signal amplifier with a frequency range of 0.05–1,000 Hz and to a peak-to-peak detector synchronized with the endocardial R wave scanning the isovolumetric contraction phase. Following standard electro-physiological studies, sensor equipped leads were temporarily inserted in the RV of 15 patients (68 ± 15 years), with normal regional and global ventricular function, to record PEA at rest, during AAI pacing, during VVI pacing, and during dobutamine infusion (up to 20 |mg/kg per min). PEA at baseline was 1.1 G ± 0.5 (heart rate = 75 ± 14 beats/rain) and increased to 1.3 G ± 0.9 (P = NS vs baseline) during AAI pacing (heart rate = 140 beats/min) and to 1.4 G ± 0.5 (P = NS vs baseline) during VVI pacing (heart rate = 140 beats/min). Dobutamine infusion increased PEA to 3.7 G ± 1.1 (P < 0.001 vs baseline), with a heart rate of 121 ± 13 beats/min. In a subset of three patients, simultaneous hemodynamic RV monitoring was performed to obtain RV dP/dtmax, whose changes during dobutamine and pacing were linearly related to changes in PEA (r = 0.9; P < 0.001). In conclusion, the PEA recording can be consistently and safely obtained with an implantable device. Pharmacological inotropic stimulation, but not pacing induced chronotropic stimulation, increases PEA amplitude, in keeping with experimental studies, suggesting that PEA is an index ofmyocardial contractility. Acute variations in PEA are closely paralleled by changes in R V dP/dtmax, but are mainly determined by LV events. The clinical applicability of the method using RV endocardial leads and an implantable device offers potential for diagnostic applications in the long-term monitoring of myocardial function in man.

Quality‐of‐Life in Patients Receiving Implantable Cardioverter Defibrillators At or Before Age 40

Abstract: As the use of ICDs increases, more young patients will be eligible to receive these devices. Such patients may have different concerns than older patients who more commonly receive ICDs. We investigated quality-of-life issues in patients followed by the Yale electrophysiology service who were < or = 40 years old (mean = 28) at the time of ICD implant. Mean time since ICD placement was 3.3 years. Each patient received a modified SF-36 health questionnaire; 16 (88%) of 18 responded. Nine were women; ten were married. The highest education level attained was high school for 6 (37%), and college or beyond for 10 (63%). Ten patients were employed; eight held the same job before and after ICD placement. Four women conceived after ICD implantation; one experienced ICD discharge during pregnancy. All delivered healthy infants. All patients felt their health was good to excellent, with 6 (38%) reporting an improvement in health since ICD placement. All felt capable of performing the activities of daily living, while 68% engaged freely in moderate physical activities. All patients felt they were average to very attractive. However, 63% worried about how their clothes fit with the ICD. Three quarters of the patients felt the ICD interfered with social interactions, while 50% were concerned about sexual encounters. Thus, even though these young patients have body image concerns and may limit their activities to some degree, they are productive, active members of society who have benefitted from ICD placement.

Atrial flutter mapping and ablation. I. Studying atrial flutter mechanisms by mapping and entrainment.

Abstract: Endocardial mapping has led to a detailed knowledge of reentry mechanisms in atrial flutter Multipolar and deflecting tip catheters allow recording local electrograms from multiple areas of the right atrium, and from the coronary sinus In common flutter, with the typical "sawtooth" pattern, there is circular activation of the right atrium in a "counterclockwise" direction, descending in the anterior and lateral walls, and ascending in the septum and posterior wall Superior and inferior vena cava, linked by a "line" of functional block in the posterolateral wall, make the central obstacle for circular activation The cranial and caudal turning points are the atrial "roof," and the isthmus between the inferior vena cava and the tricuspid valve Complex conduction patterns, probably including slow conduction are detectable in the low septal area, around the coronary sinus Atypical flutter, without the sharp negative deflections of common flutter, sometimes shows circular activation in the right atrium, rotating in the opposite direction of common flutter (clockwise) Other atypical flutters show no circular right atrial activation, and only partial data from coronary sinus activation, combined with the response to atrial stimulation (entrainment) allow the diagnosis of left atrial reentry, without a precise delimitation of the circuits In patients having undergone cardiac surgery, atypical flutter may be based on reentry around surgical scars To our knowledge, the mechanism of type II flutter has not been disclosed in humans

Idiopathic Right Ventricular Outflow Tract Tachycardia: A Clinical Approach

Abstract: Right ventricular outflow tract (RVOT) tachycardia is the most common form of idiopathic ventricular tachycardia (VT). Phenotypically, RVOT tachycardia segregates into two predominant forms, one characterized by repetitive monomorphic nonsustained VT and the other by paroxysmal exercise induced sustained VT. There is an increasing body of evidence to support the concept that both forms of tachycardia reflect disparate clinical manifestations of an identical cellular mechanism (i.e., cAMP-mediated triggered activity), which is identified clinically by the tachycardia's sensitivity to adenosine. The clinical characteristics, natural history, and approaches to therapy of RVOT tachycardia are delineated herein.

Diaphragm pacing with a quadripolar phrenic nerve electrode: an international study.

Abstract: We sought to determine the international experience with the quadripolar diaphragm pacer system and to test two hypotheses: the incidence of pacer complications would be (1) increased among pediatric as compared to adult patients; and (2) highest among active pediatric patients with idiopathic congenital central hypoventilation syndrome (CCHS). Data were collected via a questionnaire coupled with the Atrotech Registry data for a total of 64 patients (35 children and 29 adults) from 14 countries. Thoracic implantation of electrodes and bilateral pacer use each occurred in 94% of all subjects. Tetraplegic (vs pediatric CCHS) patients were more typically paced 24 hours/day (P = 0.001). Pacing duration averaged 2.0 +/- 1.0 years among children and 2.2 +/- 1.1 years among adults. Infections occurred among 2.9% of surgical procedures, all in pediatric CCHS patients (vs pediatric tetraplegic patients, P = 0.01). The incidence of mechanical trauma was 3.8%, without significant differences among patient groups. The incidence of presumed electrode and receiver failure were 3.1% and 5.9%, respectively, with internal component failure greater among pediatric CCHS than pediatric tetraplegic patients (P < 0.01). Intermittent or absent function of 0-4 electrode combinations occurred among 19% of all patients, with increased frequency among pediatric CCHS than pediatric tetraplegic patients (P < 0.03). Complication-free successful pacing occurred in 60% of pediatric and 52% of adult patients. In all, 94% of the pediatric and 86% of the adult patients paced successfully after the necessary intervention. Although pacer complications were not increased among pediatric as compared to adult patients, the incidence of complications was highest among the active pediatric patients with CCHS. Longitudinal study of these patients will provide invaluable information for modification and improvement of the quadripolar system.

Indications for Permanent Cardiac Pacing in First‐Degree AV Block: Class I, II, or III?

Abstract: Schiiller and Brandt^ recently defined the pacemaker syndrome in terms of \"symptoms and signs present in the pacemaker patient which are caused hy inadequate timing of atrial and ventricutar contractions.\" This characterization also applies to patients without an implanted pacemaker when \"inadequate timing of atrial and ventricular contractions\" causes a similar hemodynamic derangement.^'^ In this regard, Chirife et al.* have called the hemodynamic disturhance produced hy marked first-degree atrioventricular (AV) hlock as the \"pacemaker syndrome without a pacemaker,\" and indicated that it can he corrected hy implantation of a dual chamher pacemaker. Others^\"'^ have referred to this entity as the \"pseudopacemaker syndrome.\" During markedly prolonged anterograde AV conduction, the close proximity of atrial systole to the preceding ventricular systole produces the same hemodynamic consequences as continual retrograde ventriculoatrial conduction.^\"^ Patients with a markedly prolonged PR interval may or may not he symptomatic at rest. They are, of course, more likely to hecome symptomatic with mild-to-moderate levels of exercise when the PR interval does not shorten appropriately and atrial systole occurs progressively closer to the previous ventricular systole.^\"^ Thus, the hemodynamic disorder caused hy a very long PR interval on exercise resemhles the exercise-induced pacemaker syndrome produced by AAIR pacing when for a variety of reasons a paced AV interval lengthens disproportionately relatively early during exer-

Asymptomatic bradyarrhythmias as a marker for sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy.

Abstract: Sleep apnea is associated with many adverse cardiovascular sequelae, including hypertension, nocturnal angina, decreased cardiac output, and bradyarrhythmias. The purpose of this study was to determine if patients referred for pacemaker therapy with asymptomatic bradyarrhythmias have underlying sleep apnea as the etiology of their bradyarrhythmias. This study included eight patients (7 males, 1 female) referred to a cardiac electrophysiology practice for pacemaker therapy. Patients included had asymptomatic bradyarrhythmias that consisted of severe sinus bradycardia, second-degree atrioventricular block, and complete heart block. In 7 of 8 patients, the bradyarrhythmias occurred at night or during the day while asleep. No patients were conditioned athletes. Symptoms often associated with bradyarrhythmias, such as lightheadedness and syncope, were not present. However, seven patients had at least one symptom suggestive of sleep apnea, such as excessive daytime fatigue, snoring, cessation of breathing during sleep (apnea), or frequent night-time awakenings. Overnight polysomnography studies were obtained on patients who had one or more symptoms suggestive of sleep apnea. In this study 7 of 8 patients (88%) referred for pacemaker therapy with asymptomatic bradyarrhythmias were documented by polysomnography to have sleep apnea. When treated with either sleep position modification, nasal continuous positive airway pressure (nasal CPAP), or tracheostomy, all seven patients had improvement in sleep apnea symptoms and remained asymptomatic from their bradyarrhythmias without pacemaker therapy over an average follow-up period of 22 months. One patient without symptoms suggestive of sleep apnea declined pacemaker therapy and remained asymptomatic. From these results, we concluded that asymptomatic transient bradyarrhythmias may suggest a diagnosis of sleep apnea. The evaluation of a patient referred for pacemaker therapy with asymptomatic bradyarrhythmias should include questions related to sleep apnea symptoms. Establishing the diagnosis of sleep apnea may reduce the need for pacemaker therapy and permit appropriate treatment of the underlying cause of these bradyarrhythmias.

Electromagnetic Interference of Analog Cellular Telephones with Pacemakers

Abstract: The aim of this study was to verify whether there is a public health risk from the interference of analog cellular telephones with pacemakers. We used a human trunk simulator to reproduce an actual implant, and two cellular telephones working with the TACS (Total Access Communication System) standard. Results showed that the electromagnetic field radiated from the analog cellular telephones interfered with a large number of the pacemakers tested (10/25). When the telephone antenna was in close proximity to the pacemaker head, pacemaker desensitizing and sensitizing and pulse inhibition was detected at the moment of an incoming call and throughout ringing. In the worst case of pulse inhibition, the pacemaker skipped three nonconsecutive beats and then resumed its normal pacing, while the desensitizing and sensitizing phenomena persisted as long as the interfering signal was on. Pulse inhibition was also observed when the connection did not succeed. Maximum sensing threshold variation was about 186% (increase) and 62% (decrease) for desensitizing and sensitizing phenomena, respectively. It was also demonstrated that the signal emitted by analog cellular telephones during the crossing of contiguous cells could induce pacemaker pulse inhibition, but under our experimental conditions this event did not seem to pose a risk for the pacemaker patient.

Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems

Abstract: Lead fracture, occurring in approximately 1%-4% of patients, is an infrequent, but potentially catastrophic complication of permanent pacing systems. Its incidence in transvenous defibrillator systems has not been established. We analyzed data from 757 patients undergoing implantation of transvenous cardioverter defibrillator systems using the Medtronic Transvene Lead system between October 20, 1989 and June 25, 1992 to determine if site of venous approach influenced incidence of lead fracture. All patients received a 3-lead system in 1 of 3 configurations: (1) right ventricle/superior vena cava/subcutaneous patch; (2) right ventricle/coronary sinus/subcutaneous patch; or (3) right ventricle/superior vena cava/coronary sinus. Of 767 right ventricular leads placed, 523 were placed via the subclavian vein, 221 via cephalic vein, and 18 via the internal jugular (5 leads were implanted using another vein). The total number of leads is greater than the total number of patients, as five patients received a second defibrillator system if the initial system was explanted and reimplanted for any reason. Seven patients (0.9%) had right ventricular lead fracture, presenting with inappropriate defibrillator shocks (1), loss of pacing ability (3), both loss of pacing ability and inappropriate shocks (1), or increased pacing threshold (2). All patients required reoperation. All had leads placed by the subclavian venous approach, with chest X ray confirming fracture at the clavicle-first rib junction in 6 of 7 cases. Using Fisher's Exact test, the difference in lead fracture between subclavian and cephalic vein implant approached statistical significance (P = 0.08). The trend toward increased lead fracture incidence with leads placed via subclavian vein suggests that cephalic vein approach may be preferable to avoid this complication.

State of the Science: Pacemaker and Defibrillator Interference from Wireless Communication Devices

Abstract: The use of wireless communication devices has increased rapidly, with current industry estimates of 50,000,000 subscribers of cellular telephone services, a number that is expected to double by the year 2000. Because wireless communication devices emit RF signals, they have the potential to interfere with implantable devices. The mechanisms of interference and the magnitude of interference must be considered in terms of the type of wireless communication device being used and the characteristics of the individual implantable device that is exposed to the RF emission of the cellular phone. This article reviews the potential effects of wireless communication devices on implantable devices and makes initial recommendations for patients with implantable devices.

Delayed Effects of Radiofrequency Energy: Mechanisms and Clinical Implications

Abstract: Radiofrequency catheter ablation has rapidly become the treatment of choice for many supraventricular^ and ventricular^ arrhythmias. Among the factors contributing to this widespread acceptance are its high efficacy and safety, particularly the latter, since a significant subset of patients undergoing radiofrequency ablation is composed of young people with an otherwise normal heart.^'^ However, as more experience was achieved with this method, it has been observed that the effects of radiofrequency energy on myocardium might not be limited to the duration of energy delivery. Rather, delayed effects have been reported to occur for as long as several hours'* to 1 month'' after the procedure. Further, delayed effects of radiofrequency energy behave as a twoedge sword. On one hand they may be beneficial when manifesting as late disappearance of conduction through an atrioventricular accessory connection after an apparently unsuccessful radiofrequency ablation of a Wolff-Parkinson-White syndrome.^"^ On the other hand, they may be very harmful when manifesting as late complete atrioventricular block after a successful ablation of an atrioventricular node reentrant tachycardia."* Therefore, it is important to understand the mechanisms responsible for the delayed effects of radiofrequency ablation, and identify markers able to predict their occurrence.

Risk of Radiation Induced Skin Injuries from Arrhythmia Ablation Procedures

Abstract: Catheter guided ablation of cardiac arrhythmias is an effective and safe procedure for the treatment of most supraventricular and selected ventricular tachycardias. Because catheter manipulation is fluoroscopically guided, there is risk of radiation induced injury, especially during prolonged procedures. The Food and Drug Administration has recently issued a bulletin warning of the risks of acute skin injury occurring during fluoroscopically guided procedures that result in an exposure level exceeding 2 Gray units (Gy). This study was performed as an investigation into the risk of radiation induced skin injury during arrhythmia ablation procedures. The amount of radiation exposure for 500 patients who underwent ablation was calculated based upon fluoroscopy times and the entrance dose of radiation (0.02 Gy/min). The mean radiation exposure was 0.93 +/- 0.62 Gy. Although 5.6% of patients (n = 28) received enough radiation exposure to reach the threshold dose (2 Gy) for early transient erythema, no clinical manifestations of acute radiation induced skin injury were observed. No patients achieved the threshold dose for irreversible skin injury. Patients undergoing AV node ablation or modification received significantly less radiation (0.39 +/- 0.40 Gy and 0.79 +/- 0.44 Gy, respectively) than patients undergoing other ablation procedures (0.94-1.45 Gy, P < 0.05). There was no association between the magnitude of radiation exposure and the presence of underlying heart disease. Patients undergoing ablation of accessory pathways were exposed to more radiation if there was a right-sided pathway (1.69 +/- 0.93 Gy) compared to other sites (0.87-1.24 Gy, P < 0.05). This study demonstrates that the risk of significant radiation induced skin injury during arrhythmia ablation procedures is low provided that precautions are taken to minimize radiation exposure.

The Steroid‐Eluting Electrode: A 10‐Year Experience

Abstract: The benefits of steroid-eluting electrodes in reducing stimulation thresholds are well established. A question frequently asked, however, is how long does such an electrode maintain its effect on reducing stimulation threshold? Two studies were designed to answer this question by reporting a long-term prospective human implant review as well as an analytical examination of explanted leads from both humans and animals to determine the amount of remaining steroid in the silicone plug. A previously reported double-blind human study using 20 implanted unipolar ventricular leads, 10 with and 10 without steroid, was followed for 10 years. Pulse width stimulation thresholds were determined at regular intervals using a customized VVIC pulse generator programmed to 1.5-V output. Throughout the study period, the mean stimulation thresholds for the steroid-eluting leads remained almost constant, with a narrow standard deviation, whereas the leads without steroid showed an unpredictable rise and a wide standard deviation. All patients with the steroid-eluting electrodes were paced at 1.5 V, and the four surviving patients still have their original pulse generators. In the second study, the remaining steroid from 25 explanted leads (18 canine and 7 human), were analyzed and graphed against implant times that ranged from 1-350 weeks. Extrapolation of the line of best fit suggests that about 20% of the steroid is still present at 10 years and 18% at 20 years. Only small quantities of steroid are required for its stimulation threshold lowering effect, which continues clinically to at least 10 years. Sufficient quantity of steroid may well be present at 20 years.

Transesophageal echocardiographic guidance of transseptal left heart catheterization during radiofrequency ablation of left-sided accessory pathways in humans.

Abstract: UNLABELLED Radiofrequency ablation (RFA) of left-sided accessory pathways can be achieved using catheters introduced by a retrograde or transseptal approach. Transesophageal echocardiography (TEE) has previously been demonstrated to be safe and efficacious in guiding transseptal puncture in patients during mitral valvuloplasty (MV). This study was undertaken to assess the feasibility, safety, and clinical utility of TEE during transseptal puncture and RFA of left-sided accessory pathways. METHODS TEE was performed during transseptal puncture in 30 patients (41 +/- 12 years, 19 females), 15 patients during attempted RFA of a left-sided accessory pathway and 15 patients during attempted balloon MV. RESULTS There was no difference in age, sex distribution, or procedural complications when MV patients were compared to RFA patients. At baseline, left atrial dimension was increased and congestive heart failure was more common when MV patients were compared to RFA patients (P < 0.05) Adequate baseline two-dimensional and Doppler TEE images were obtained in all patients. One patient sustained mild esophageal bleeding during the TEE. Positioning of the transseptal catheter in the fossa ovalis was facilitated and confirmed by TEE in 29 of 30 cases. One case of cardiac perforation occurred and was associated with inadequate TEE localization of the fossa ovalis. Thrombus was detected on the transseptal catheter by TEE in two cases prior to systemic heparinization. In both cases, thrombus was removed without embolic event. CONCLUSIONS TEE safely guides transseptal puncture in patients undergoing RFA of left-sided accessory pathways. TEE markers of the fossa ovalis facilitate puncture and may reduce the risk of cardiac perforation particularly in patients with a normal size left atrium. TEE may be especially valuable for identifying thrombus during transseptal puncture.

Three-year experience with a stylet for lead extraction: a multicenter study.

Abstract: INTRODUCTION The extraction of chronically implanted and infected pacemaker and defibrillator leads is an important issue. This article describes the experience gathered between 1990 and 1994 by seven European centers regarding a locking stylet that is uniformly applicable for a wide variety of internal pacing coil diameters. This interventional locking stylet for lead extraction has an outer diameter of 0.4 mm (0.016 inches). The stylet consists of a hollow shaft in which an inner traction wire is embedded. At the tip of the inner traction wire an anchoring mechanism, which can be opened by retraction, is applied. Removal attempts were made for 150 leads, 110 in ventricular and 40 in atrial positions. RESULTS Complete removal was possible in 122 cases (81%). Partial removal was possible in 18 cases (12%). Failure to remove the lead with the extraction stylet was experienced in 10 cases (7%). In seven patients, the leads were removed by cardiothoracic surgery; 3 defective leads were left in place. There were no serious complications associated with the procedure. None of the patients died. CONCLUSION The experience with this extraction stylet for lead removal has shown good results. Despite a low complication rate thus far, each case for lead removal should be judged on the individual basis of benefit-to-risk ratio.

The use of methylphenidate in the treatment of refractory neurocardiogenic syncope.

Abstract: Recurrent neurocardiogenically mediated episodes of hypotension and bradycardia are a common cause of recurrent syncope that can be identified by head upright tilt table testing. While the use of beta-blockers, theophylline, fludrocortisone, disopyramide, and serotonin re-uptake inhibitors can be helpful in preventing further episodes, some patients are unresponsive to or poorly tolerant of these agents. We investigated the use of the central nervous system stimulant and peripheral vasoconstrictor methylphenidate in preventing both tilt induced and spontaneous neurocardiogenic syncope. Seven patients (all women, mean age 31 +/- 15 years) with recurrent syncope and positive head upright tilt induced hypotension/bradycardia (refractory to normal therapy) were placed on methylphenidate 10 mg orally three times per day. Six of the seven patients became both tilt negative and clinically asymptomatic over a 7-month follow-up period. We conclude that methylphenidate may be an effective therapy in patients with recurrent neurocardiogenic syncope refractory to other forms of therapy.

A conceptual basis for defibrillation waveforms.

Abstract: A model is developed for defibrillation that treats the heart as a first order time constant. Such a model allows ready evaluation of different monophasic waveforms. For implantable devices where the voltage is provided by the discharge of a capacitor, it can be seen that the effective voltage within the heart rises rapidly to a peak and then decays to zero. The time interval at which this peak occurs is defined as the optimal duration, and there is no advantage in extending the pulse beyond this point. Characteristics are presented that show how the time course of this voltage within the heart changes with different device capacitors and load impedances. The effect of different heart time constant are also examined. For biphasic waveforms, a contour plot of threshold voltage is presented with phase 1 and phase 2 durations on the two axes. It is seen that there is a region of reliable low threshold defibrillation from 3.5/1.5 ms to 9/6 ms.

Comparison of bipolar atrial electrogram amplitude in sinus rhythm, atrial fibrillation, and atrial flutter.

Abstract: Automatic mode switching pacemakers revert to non-atrial tracking modes in response to sensed atrial tachyarrhythmias. It is unclear how atrial electrogram amplitudes in sinus rhythm compare to those during atrial tachyarrhythmias. In this study, peak-to-peak bipolar atrial electrogram amplitudes were measured during sinus rhythm and either atrial fibrillation or atrial flutter in 69 patients. The mean atrial electrogram amplitudes were 1.59 +/- 1.36 mV during sinus rhythm and 0.77 +/- 0.58 mV during atrial fibrillation (P < 0.0001) for 25 patients with atrial fibrillation and 1.81 +/- 2.07 mV during sinus and 1.5 +/- 1.81 mV (P < 0.0001) for 44 patients with atrial flutter. The mean electrogram amplitudes during both atrial fibrillation and flutter correlated significantly with amplitudes during sinus rhythm (R = 0.79, R = 0.94, respectively, both P < 0.0001). The coefficient of variance of individual electrogram amplitudes was greater in atrial fibrillation than sinus (P < 0.0001). By comparing 20th percentile electrogram amplitudes in atrial fibrillation and flutter to mean sinus amplitudes, intermittent very low electrogram amplitudes (< 0.3 mV) were more likely during atrial fibrillation and flutter if the mean sinus electrogram amplitudes were < 1.5 mV and < 0.5 mV, respectively (P < 0.01). Eightieth percentile electrogram amplitude values in atrial fibrillation and flutter were equally likely to exceed mean sinus amplitude values in respective patients. In conclusion, mean atrial electrogram amplitudes during atrial fibrillation and flutter are less than but correlated to sinus rhythm electrogram amplitudes. Very low amplitude individual electrograms during these atrial arrhythmias are associated with low mean sinus rhythm electrogram amplitudes. These findings may have implications for the programming of permanent dual chamber pacemakers in patients with paroxysmal atrial fibrillation and flutter.

Atrial flutter mapping and ablation II. Radiofrequency ablation of atrial flutter circuits.

Abstract: The definition of the anatomical substrate of reentry in atrial flutter has allowed the recognition of narrow, critical areas of the circuit, where radiofrequency ablation can interrupt reentry. In common flutter the isthmus between the inferior vena cava and the tricuspid valve appears the best target, but ablation between the coronary sinus and tricuspid valve can also be effective in some cases. In atypical flutter using the same circuit as common flutter in a "clockwise" direction, ablation of the same isthmus is effective. Flutter interruption is the main objective, but it does not mean complete isthmus ablation. If flutter remains inducible, new applications are delivered in the isthmus, until it is made noninducible. Complications are rare. Despite attaining noninducibility, flutter may recur, and new procedures may be needed to prevent recurrence. Atrial fibrillation can occur in up to 30% of the cases during follow-up, but it is generally well controlled with antiarrhythmic drugs, that were ineffective to treat flutter before ablation. In reentry circuits based on surgical atrial scars, ablation of an isthmus between the scar and the inferior vena cava can also be effective. Left atrial circuits are not known well enough to guide successful ablation.

Incidence of perforation and other mechanical complications during dual active fixation.

Abstract: The intraoperative and early postoperative mechanical complications of a procedure combining an atrial screw-in lead and a ventricular screw-in lead insertion were prospectively evaluated. The procedure was performed in 119 consecutive patients (mean age 69 +/- 8 years), at first implant in 100 patients and at reoperation in 19. Nine patients had previously undergone cardiac surgery and three underwent transvenous ventricular defibrillator implantation. The double sets of leads were introduced through 2 separate veins in 5 cases, through a single venous route in 114 cases, using a percutaneous approach in 75 cases and a venous cutdown in 49, and a guidewire procedure following the venotomy in 19. The screw was mannitol coated in 102 cases, exposed in 111, and extendable/retractable in 25. The fixation of the ventricular lead was performed at the apex in 108 cases, at the outflow tract in 11, and was followed by the fixation of the atrial lead at the appendage in 112 cases and at the lateral wall in 7 cases. The lead positioning and fixation were successful at first attempt in 103 cases and after repeated lead manipulation in 19 cases. The rotational torque could be transferred to the helix in all cases except in one patient who required a second vein puncture. Unintentional fixation in the ventricular chamber with subsequent failure to remove the lead occurred in one patient. Reoperation for lead dislodgment was required in two patients. In one patient, symptomatic pericarditis with pericardial effusion was observed 1 day after the procedure and resolved spontaneously. Dual active fixation is feasible with a low incidence of mechanical complications.

Heart rate variability after cardiac transplantation in humans

Abstract: The reappearance of cardiac innervation after cardiac transplantation remains a matter of debate. We evaluated the ability of heart rate variability (HRV) analysis to detect the extent and time course of functional cardiac allograft reinnervation. Time- and frequency-domain analysis of heart rate was performed on Holter recordings of 120 heart transplant and four heart-lung transplant recipients. A high frequency (HF) component was clearly distinguished on visual inspection of power spectral density in 42 patients. In eight patients an HF component of normal magnitude was detected. The other 34 patients in this group, including all four heart-lung transplants, presented with a very small HF component. The other 82 patients showed a flat spectrum. The group with an HF component of normal amplitude was significantly different, compared to the other groups, for all HRV parameters. Serial plotting of HRV parameters of the patients with an HF component of normal amplitude against time posttransplant, revealed, from 12 months onwards, a progressive increase of parameters denoting HF variability. In five heart transplant patients with acute allograft rejection, the use of HRV analysis for rejection monitoring was unsuccessful. These results suggest that, inasmuch as the HF component of HRV is caused by parasympathetic cardiac innervation, the HF component of normal amplitude, observed in only a minority of cardiac transplant recipients (6%), is a marker for parasympathetic reinnervation. The evolution over time of this HF component is compatible with a biological phenomenon as gradual parasympathetic reinnervation of the sinus node.

Decreased heart rate variability in patients with congestive heart failure and chronotropic incompetence

Abstract: Heart rate variability was studied in 41 patients (aged 48 ± 12 years) with congestive heart failure secondary to idiopathic dilated cardiomyopathy. All patients underwent a treadmill exercise test and 24-hour Holter ECC monitoring. Chronotropic incompetence was defined as the failure to achieve > 80% of the predicted maximal heart rate response given by 220 – age (years) at peak exercise. Spectral heart rate variability was analyzed from 24-hour Holter ECCs and was expressed as total (0.01–1.00 Hz), low (0.04–0.15 Hz), and high (0.15–0.40 Hz) frequency components. The standard deviation of all normal RR intervals (SDNN) was also computed. Chronotropic incompetence was observed in ten patients. Peak oxygen consumption was significantly lower in patients witb chronotropic incompetence compared with those without chronotropic incompetence. The total (5.11 ± 1.26 In [ms2] vs 6.41 ± 0.92 In [ms2]; P = 0.009) and low (3.38 ± 1.65 In [ms2] vs 5.45 ± 1.34 In [ms2];P = 0.003), but not the high (3.42 ± 1.04 In [ms2] vs 4.00 ± 1.12 in [ms2]; P = 0.249) frequency components of heart rate variability were significantly lower in patients with chronotropic incompetence, although there was no significant difference in mean heart rate (88 ± 20 beats/min vs 86 ± 15 beats/min; P = 0.831) or left ventricular ejection fraction (22%± 10% vs 24%± 10%; P = 0.619). SDNN was also significantly lower in patients with chronotropic incompetence compared witb those without chronotropic incompetence (64 ± 34 ms vs 102 ± 37 ms; P = 0.030). Conclusions: The observation that heart rate variability is significantly decreased in patients with congestive heart failure who have chronotropic incompetence suggests that chronotropic incompetence may relate to an abnormal autonomic influence on the heart in these patients.

Acute effects of radiofrequency ablation of atrial arrhythmias on implanted permanent pacing systems.

Abstract: We studied the safety of performing RF catheter ablation in patients with implanted permanent pacemakers by monitoring the function of implanted pacing systems before, during, and immediately after exposure to RF energy. Patients with implanted pacing systems may require RF ablation for treatment of a variety of tachyarrhythmias. High frequency electromagnetic fields, such as RF energy, may affect implanted pacing systems, causing temporary or permanent loss of output, undersensing, oversensing, asynchronous pacing, or reversion to "reset" (Recommended Replacement Time or Power On Reset) parameters. Thirty-five patients with implanted pacing systems (23 DDDR, 6 VVIR, 5 DDD, 1 VVI, 31 bipolar and 4 unipolar) underwent RF catheter ablation. Prior to ablation, each pacing system underwent measurements of pacing and sensing thresholds, telemetry of intracardiac electrograms and measurement of battery voltage and lead impedance(s). During ablation, pacemaker function was monitored by real-time telemetry, intracardiac electrograms, and surface ECG. Immediately after ablation, each pacing system was reevaluated. Telemetry during RF ablation revealed normal pacing and sensing in 14 (40%) of 35 patients. Refractory period extension with asynchronous pacing and noise mode reversion were seen in 16 (46%) of 35 patients. Rare under- and/or oversensing, reversion to reset parameters, and telemetry "lock up" with inhibition of pacing output was seen in a few patients. After ablation, there were no significant changes in atrial or ventricular pacing or sensing thresholds or measurements of atrial and ventricular lead impedances. We conclude that most permanent pacemakers are not adversely affected by exposure to RF energy during catheter ablation. A variety of pacemaker behaviors may be seen during RF ablation, and a thorough understanding of each pulse generator's potential response(s) to electromagnetic interference is important before undertaking catheter ablation in patients with permanent pacemakers. Careful reevaluation of the patient's pacing system following the procedure is mandatory.